GE Medical Systems' bid for globalultrasound domination took a step forward last month when theFood and Drug Administration issued 510(k) marketing clearancefor its mid-range Logiq 500 scanner. GE now has the regulatorygo-ahead to sell both of the
GE Medical Systems' bid for globalultrasound domination took a step forward last month when theFood and Drug Administration issued 510(k) marketing clearancefor its mid-range Logiq 500 scanner. GE now has the regulatorygo-ahead to sell both of the scanners in the Logiq series.
Milwaukee-based GE lifted the wraps on Logiq 500 at the InternationalCongress of Radiology meeting in Singapore in January, two monthsafter Logiq 700 debuted at last year's Radiological Society ofNorth America conference (SCAN 4/6/94 and 12/15/93).
Logiq 500 is designed to be a more portable, economical versionof the premium Logiq 700. Logiq 500 features 64-channel all-digitalarchitecture and is half the size and weight of Logiq 700.
GE began marketing Logiq 500 in Asia late last year and inEurope earlier this year. GE will begin shipping the scanner inthe U.S. in August, according to the company. Shipments of Logiq700 will begin in October, after the company finishes rampingup its manufacturing operations and putting the final toucheson the system's software.
GE's ultrasound business also received ISO 9000 certificationin June, according to the company.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.